ULBI ULTRALIFE CORP
Miscellaneous Electrical Machinery, Equipment & Supplies · Nasdaq · SEC CIK 875657 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.0%
TTM net income YoY-272.4%
TTM EPS YoY-192.3%
Revenue 3-yr CAGR8.6%
Net income 3-yr CAGR—
Margins
Gross margin25.7%
Operating margin-2.2%
Net margin-1.5%
FCF margin-0.4%
EBITDA margin0.0%
Returns
ROE-2.2%
ROA-1.3%
ROIC (approx.)-1.9%
Asset turnover0.86x
Leverage & solvency
Liabilities / assets40.0%
Debt / equity0.38x
Current ratio2.97x
Interest coverage-1.18x
Cash quality & payout
Operating cash flow / net income-0.68x
Accruals ratio-2.2%
Payout ratio—
Capex / revenue1.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $191.16M | $164.46M |
| Cost of revenue | $145.14M | $122.14M |
| Gross profit | $46.02M | $42.31M |
| R&D expense | $10.40M | $8.27M |
| SG&A expense | $29.34M | $24.08M |
| Operating income | -$5.90M | $9.96M |
| Interest expense | $3.95M | $1.94M |
| Pretax income | -$8.40M | $8.30M |
| Income tax | -$2.45M | $1.89M |
| Net income | -$5.90M | $6.31M |
| EBITDA | -$1.92M | $13.09M |
| EPS (basic) | -35.00 | 38.00 |
| EPS (diluted) | -35.00 | 38.00 |
| Weighted avg. shares (diluted) | 16.64M | 16.77M |
| Balance sheet | ||
| Cash & equivalents | $9.35M | $6.85M |
| Receivables | $33.95M | $29.37M |
| Inventory | $54.01M | $51.36M |
| Current assets | $105.80M | $97.16M |
| PP&E, net | $40.40M | $40.48M |
| Goodwill | $45.38M | $45.01M |
| Intangibles | $10.93M | $24.56M |
| Total assets | $216.91M | $220.45M |
| Current liabilities | $37.33M | $29.29M |
| Short-term debt | $4.12M | $2.75M |
| Long-term debt | $45.53M | $51.50M |
| Total debt | $49.65M | $54.25M |
| Total liabilities | $86.78M | $86.26M |
| Shareholders' equity | $130.00M | $134.00M |
| Net debt | $40.31M | $47.40M |
| Shares outstanding | 16.66M | 16.63M |
| Cash flow statement | ||
| Operating cash flow | $10.99M | $16.64M |
| Capital expenditure | $3.87M | $1.93M |
| Free cash flow | $7.12M | $14.70M |
| Investing cash flow | -$3.87M | -$49.95M |
| Financing cash flow | -$4.68M | $29.86M |
| Depreciation & amortization | $3.98M | $3.12M |
| Stock-based compensation | $935,000 | $698,000 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.